Company intelligence / Profile preview
AbCellera Biologics
Vancouver, British Columbia, Canadaabcellera.com ↗
- Ownership
- Public · ABCL
- Development stage
- Other
01
Overview
AbCellera's mission is to improve health with technologies that rationalize and accelerate the discovery of next-generation antibody therapeutics. The company operates as a platform technology company using an integrated AI-powered system combining microfluidics, machine learning, and genomics to discover antibody candidates rapidly. The company has 10 molecules in the clinic as of 2024. Recent progress includes two Phase 1 programs initiated in 2025 (ABCL635 for menopausal vasomotor symptoms and ABCL575 for atopic dermatitis) and ABCL688 entering IND-enabling studies. AbCellera operates 106 discovery programs under contract with 42 distinct partners.
- Therapeutic areas
- ImmunologyWomen's HealthNeurologyDermatologyInfectious DiseasesRheumatologyOncology
- Modalities
- Monoclonal antibody
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
04
Financials
- Market cap
- $3.6B
- Total revenue
- $75.1M
- Enterprise value
- $3.2B
Beyond the preview
Go deeper on AbCellera Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AbCellera Biologics.